Dermatitis herpetiformis future or investigational therapies
|
Dermatitis herpetiformis Microchapters |
|
Differentiating Dermatitis herpetiformis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Dermatitis herpetiformis future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Dermatitis herpetiformis future or investigational therapies |
|
FDA on Dermatitis herpetiformis future or investigational therapies |
|
CDC on Dermatitis herpetiformis future or investigational therapies |
|
Dermatitis herpetiformis future or investigational therapies in the news |
|
Blogs on Dermatitis herpetiformis future or investigational therapies |
|
Risk calculators and risk factors for Dermatitis herpetiformis future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dermatitis Herpetiformis (also called Duhring's disease), is a chronic itchy rash which is frequently associated with Celiac Disease. The rash is made of papules and vesicles which are present on different parts of the body mostly commonly on neck, trunk, buttocks and knees. It is an autoimmune mediated skin condition, which is IgA mediated reaction and is associated with gluten sensitivity of small bowel. There is presence of antibodies which leads to positive serology test results.
Dermatitis herpetiformis is associated with high prevalence of other autoimmune diseases.
Future or Investigational Therapies
There are no further therapies for dermatitis herpetiformis.